BRIEF-Bristol-Myers says EU advanced melanoma drug

* European Commission Approves The First And Only

Immuno-Oncology Combination, Bristol-Myers Squibb's Opdivo

(Nivolumab) + Yervoy (Ipilimumab) Regimen, For Treatment Of

Advanced Melanoma

Read more